Capsular Contracture Associated With Breast Implant: Clinical Trials

3 trials for Capsular Contracture Associated With Breast Implant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 withdrawn. 2 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Recruiting 2
Phase 41Withdrawn 1

Follow Capsular Contracture Associated With Breast Implant: new trials by email Literature Review of Capsular Contracture Associated With Breast Implant trials Research Report on Capsular Contracture Associated With Breast Implant

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
GalaFLEX LITE™ Scaffold, Standard surgery - Capsular Contracture Associated With Breast Implant, Capsular Contracture Grade III
Not applicableRecruitingC. R. Bard2502024-12-122026-09-25
Postoperative Antibiotics Following Primary and Secondary Breast Augmentation
Cefazolin, Cephalexin, Placebo - Surgical Site Infection, Capsular Contracture Associated With Breast Implant
Phase 4WithdrawnUniversity of California, Los Angeles2021-04-012022-09-14
Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction
NovaGray RILA Breast® test - Breast Cancer, Capsular Contracture Associated With Breast Implant
Not applicableRecruitingInstitut du Cancer de Montpellier - Val d'Aurelle2502020-12-112026-04-13

Narrower conditions

Breast Neoplasms (1)  ·  Surgical Wound Infection (1)

Broader conditions

Breast Diseases (1)  ·  Infections (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Postoperative Complications (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Wound Infection (1)

Interventions

Cefazolin (1)  ·  Cephalexin (1)  ·  Clindamycin (1)

Sponsors

C. R. Bard (1)  ·  Institut du Cancer de Montpellier - Val d'Aurelle (1)  ·  University of California, Los Angeles (1)

Countries

France (1)  ·  United States (1)

Top investigators

Jaco Festekjian, MD (1)  ·  Karie Villanueva, MD (1)  ·  Marian Gutowski (1)

Results publications

PMID 21336948